MedTrace Logo

Clinical Phenotyping and Genotyping of HIV-Associated Sensory Neuropathy: The HIV-POGO Study

NCT02555930 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 148

Last updated 2021-03-23

Study results available
· View outcomes & findings →

Summary

This study aims to recruit a cohort of HIV patients with and without HIV-SN and to identify genetic risk factors for the development of HIV-SN and neuropathic pain. It also aims to more deeply phenotype the condition, using well validated questionnaires, and to identify any influence that early neurocognitive dysfunction may have on the reporting, diagnosis and treatment of neuropathic pain in the HIV population.

Conditions

  • HIV
  • Sensory Neuropathy
  • Neuropathic Pain

Interventions

OTHER

No Intervention

No intervention - observational only

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Principal Investigators

  • Andrew SC Rice, Prof · Imperial College London

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-01
Primary Completion
2019-01-01
Completion
2019-01-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02555930 on ClinicalTrials.gov